Gender difference in the response to an angiotensin-converting enzyme inhibitor and a diuretic in hypertensive patients of African descent

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Hypertension

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00004872-200406000-00023PMID 15167457
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enalapril and hydrochlorothiazide in hypertensive Africans

  2004cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.

  2003cited by this paper
• Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

  2003cited by this paper
• Health outcomes associated with various antihypertensive therapies used as first-line agents

  2003cited by this paper
• A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

  2003cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• Monitoring one-year compliance to antihypertension medication in the Seychelles.

  2002cited by this paper
• Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs

  2002cited by this paper
• Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa.

  2001cited by this paper
• Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. MIST II Trial Investigators.

  2000cited by this paper
• Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

  2000cited by this paper
• Antihypertensive Effect of Low‐Dose Hydrochlorothiazide Alone or in Combination with Quinapril in Black Patients with Mild to Moderate Hypertension

  2000cited by this paper
• Guidelines for the management of hypertension.

  2000cited by this paper
• Sustained antihypertensive actions of a dual angiotensin-converting enzyme neutral endopeptidase inhibitor, sampatrilat, in black hypertensive subjects.

  1999cited by this paper
• Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension.

  1999cited by this paper
• Guidelines for management of hypertension: report of the third working party of the British Hypertension Society

  1999cited by this paper
• Optimisation of antihypertensive treatment by crossover rotation of four major classes.

  1999cited by this paper
• Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.

  1998cited by this paper
• Renin status does not predict the anti-hypertensive response to angiotensin-converting enzyme inhibition in African–Americans

  1998cited by this paper
• Nocturnal reduction of blood pressure and the antihypertensive response to a diuretic or angiotensin converting enzyme inhibitor in obese hypertensive patients. TROPHY Study Group.

  1998cited by this paper
• Compliance with antihypertensive treatment: implications for practice.

  1997cited by this paper
• Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study.

  1996cited by this paper
• Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group.

  1995cited by this paper
• Effectiveness of enalapril in combination with low-dose hydrochlorothiazide versus enalapril alone for mild to moderate systemic hypertension in black patients.

  1994cited by this paper
• Nifedipine versus captopril in the management of moderate hypertension in black patients.

  1994cited by this paper
• Within‐patient correlation between the antihypertensive effects of atenolol, lisinopril and nifedipine

  1994cited by this paper
• Comparison of the efficacy and tolerability of Prinivil and Procardia XL in black and white hypertensive patients.

  1992cited by this paper
• The efficacy of hydrochlorothiazide, timolol and enalapril in Ethiopians with essential hypertension.

  1992cited by this paper
• Comparison of the efficacy and tolerability of lisinopril and sustained-release verapamil in black patients with hypertension.

  1991cited by this paper
• High prevalence of cardiovascular risk factors in the Seychelles (Indian Ocean).

  1991cited by this paper
• Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin.

  1990cited by this paper
• Trials using a crossover design and ambulatory blood pressure recordings to determine the efficacy of antihypertensive agents in individual patients.

  1990cited by this paper
• Treating the individual hypertensive patient: considerations on dose, sequential monotherapy and drug combinations.

  1990cited by this paper
• Diabetic nephropathy in normotensive patients

  1990cited by this paper
• Prevention of renal hypertension in the rat by neuropeptide Y.

  1990cited by this paper
• A Comparison of the Efficacy and Safety of a β-Blocker, a Calcium Channel Blocker, and a Converting Enzyme Inhibitor in Hypertensive Blacks

  1990cited by this paper
• A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks.

  1990cited by this paper
• The Antihypertensive Response to Lisinopril: The Effect of Age in a Predominantly Black Population

  1989cited by this paper
• Antihypertensive drugs and sodium restriction. Analysis of their interaction based on pressure-natriuresis relationship.

  1988cited by this paper
• Individual responses to converting enzyme inhibitors and calcium antagonists.

  1988cited by this paper
• Demography Predicts Blood Pressure Response to Once-Daily Enalapril Monotherapy of Mild to Once-Daily Enalapril Monotherapy of Mild to Moderate Essential Hypertensive Patients

  1988cited by this paper
• Crossover design to test antihypertensive drugs with self-recorded blood pressure.

  1988cited by this paper
• Demography predicts blood pressure response to once-daily enalapril monotherapy of mild to moderate essential hypertensive patients.

  1988cited by this paper
• Comparison of enalapril and thiazide diuretics in the elderly hypertensive patient.

  1987cited by this paper
• Comparison of the antihypertensive effect of enalapril and propranolol in black South Africans.

  1985cited by this paper
• Antihypertensive and metabolic effects of a new converting enzyme inhibitor, enalapril

  1983cited by this paper
• Responses to captopril and hydrochlorothiazide in black patients with hypertension

  1982cited by this paper
• Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide.

  1982cited by this paper

• Sex-Specific Differences in the Pathophysiology of Hypertension

  2025cites this paper
• The impact of reproductive steroids on autosomal dominant polycystic kidney disease progression in women.

  2025cites this paper
• Choosing the Right Angiotensin Converting Enzyme Inhibitors; Gender –Specific Approach

  2024cites this paper
• Breakthrough: a first-in-class virtual simulator for dose optimization of ACE inhibitors in translational cardiovascular medicine

  2023cites this paper
• Sex Differences in Glomerular Lesions, in Atherosclerosis Progression, and in the Response to Angiotensin-Converting Enzyme Inhibitors in the ApoE−/− Mice Model

  2023cites this paper
• Sex Differences in the Renal Vascular Responses of AT1 and Mas Receptors in Two-Kidney-One-Clip Hypertension

  2021cites this paper
• Sex differences in solute and water handling in the human kidney: Modeling and functional implications

  2021cites this paper
• Sex differences in stroke co-morbidities.

  2020cites this paper
• Salt Reduction to Prevent Hypertension and Cardiovascular Disease: JACC State-of-the-Art Review.

  2020cites this paper
• Distal Convoluted Tubule Sexual Dimorphism Revealed by Advanced 3D-Imaging.

  2020cites this paper
• Pharmacotherapy for hypertension in Sub-Saharan Africa: a systematic review and network meta-analysis

  2020cites this paper
• Sex-specific long-term blood pressure regulation: Modeling and analysis

  2019cites this paper
• Sex and salt intake dependent renin-angiotensin plasticity in the liver of the rat

  2019cites this paper
• Patient characteristics do not predict the individual response to antihypertensive medication: a cross-over trial

  2018cites this paper
• Sodium intake affects gender difference in aldosterone concentration.

  2017cites this paper
• Gender Differences in Response to Therapy for Cardiovascular Diseases

  2017cites this paper
• Sodium intake affects sex difference in aldosterone concentration

  2017cites this paper
• Role of the endothelin system in sexual dimorphism in cardiovascular and renal diseases.

  2016cites this paper
• Sexually dimorphic proteinuria in Wistar rats: Relevance to clinical models.

  2016cites this paper
• Differences in angiotensin (1-7) between men and women.

  2015cites this paper
• Angiotensin II Type 2 Receptor– and Acetylcholine-Mediated RelaxationNovelty and Significance

  2015cites this paper
• Gender differences in response to acute and chronic angiotensin II infusion: a translational approach

  2015cites this paper
• Recommendations concerning the new U.S. National Institutes of Health initiative to balance the sex of cells and animals in preclinical research

  2015cites this paper
• Evolution of clinical profile, treatment and blood pressure control in treated hypertensive patients according to the sex from 2002 to 2010 in Spain

  2015cites this paper
• Female renal health: translational studies on renal hemodynamics and the renin-angiotensin aldosterone system

  2015cites this paper
• Angiotensin II type 2 receptor- and acetylcholine-mediated relaxation: essential contribution of female sex hormones and chromosomes.

  2015cites this paper
• What are the Molecular Mechanisms Driving Sex Differences in BP in Hypertension ?

  2013cites this paper
• Hypertension: what's sex got to do with it?

  2013cites this paper
• Sex-related differences in pharmacokinetics and pharmacodynamics of anti-hypertensive drugs

  2012cites this paper
• Y Are Males So Difficult to Understand?: A Case Where “X” Does Not Mark the Spot

  2012cites this paper
• Discontinuation of angiotensin‐converting enzyme inhibitors: a cohort study

  2011cites this paper
• Nutrition in cardiovascular disease: salt in hypertension and heart failure.

  2011cites this paper
• Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials.

  2011cites this paper
• Gender and the renin–angiotensin–aldosterone system

  2010cites this paper
• Electronic monitoring of patient adherence to oral antihypertensive medical treatment: a systematic review

  2009cites this paper
• Sex differences in ambulatory blood pressure monitoring.

  2008cites this paper
• Hemodynamic effect of angiotensin II receptor blockade in postmenopausal women on a high-sodium diet: A double-blind, randomized, placebo-controlled study.

  2008cites this paper
• Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition.

  2008cites this paper
• CYP3A5 and ABCB1 Genes Influence Blood Pressure and Response to Treatment, and Their Effect Is Modified by Salt

  2007cites this paper
• Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?

  2007cites this paper
• Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).

  2007cites this paper
• Telmisartan/hydrochlorothiazide: a new fixed dose combination

  2005cites this paper
• Nitric oxide Related review: Nitric oxide and superoxide in the renal medulla: a delicate balancing act (pp. 9–15)

  2004cites this paper